Great work Red Bar, the reality is there are a lot of traders...

Great work Red Bar, the reality is there are a lot of traders and HC'ites on this one who probably haven't really looked into things to much and will either be disappointed by the revenue this quarter or will 'sell the news' I for one will continue to buy the dips, and why wouldn't you if the fundamentals keep firming up and improving... If it's Tempur Pedic utilising Alexiflam-NF and we're told they're expanding use across more and more lines how big could that one deal become?

In regard to your other post re YMYC, interesting how on the back foot their responses were, just goes to show how often they bulls**t and when confronted with fundamentals they fall back on "the proof will be in the pudding". Was this the same panel that said sub 40 cents was where AJX was heading?